Bausch + Lomb Launches PreserVision AREDS3

 Bausch + Lomb has introduced PreserVision AREDS3, an over-the-counter oral supplement designed to reduce the risk of disease progression in patients with age-related macular degeneration (AMD).

Key Features & Formulation

  • Core Nutrients: Contains the complete, National Eye Institute-recommended AREDS2 formula to protect macular health by neutralizing free radicals (vitamins C and E, lutein, zeaxanthin, zinc, and copper).

  • New B-Vitamin Complex: Adds thiamin, riboflavin, niacin, pantothenic acid, vitamin B6, biotin, folate, and vitamin B12 to promote healthy cellular eye function.

  • Enhanced Absorption: Offers approximately twice the nutrient absorption of previous AREDS formulations.

Scientific Backing

The inclusion of B vitamins is supported by over two decades of research across more than 20 human studies (including the Women’s Antioxidant and Folic Acid Cardiovascular Study), which tie specific B-vitamin supplementation to a reduced risk of AMD. Bausch + Lomb plans to conduct a long-term clinical trial to further evaluate this new formulation.

The supplement is currently available at most major retailers nationwide. For more details, you can visit PreserVision.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

Keratoconus and Inflammatory Skin Conditions

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH